Acquisition leverage Zicam was acquired by Church & Dwight in 2020 for 530 million, indicating access to substantial distribution channels, capital for marketing, and potential lines of synergy that can be leveraged for co-branding or cross-sell opportunities.

Pharmacist trust Recognized as the #1 Pharmacist Recommended Brand in 2021, highlighting strong credibility and educator-friendly product positioning that can be used to open conversations with retailers, pharmacies, and healthcare partners.

Market leadership VMS category leadership in zinc supplements and prominent status in cough/cold segments suggest opportunities to upsell bundled OTC portfolios, seasonal promotions, and repeat purchase programs in pharmacy and mass-retail channels.

Growth constraints Current revenue under $1M with a lean employee base (11–50) implies a need for scalable partnerships, private-label or contract manufacturing options, and selective channel expansion to achieve higher margins and broader reach.

Digital & security fit tech stack includes WordPress, OneTrust, Azure, and other enterprise tools indicating solid digital presence and governance; potential for digital marketing partnerships, e-commerce optimization, and enhanced data privacy-compliant campaigns to accelerate growth.